Report Detail
Global Genetic Disease Diagnostic Market 2024 by Company, Regions, Type and Application, Forecast to 2030
- RnM3878491 |
- 26 September, 2024 |
- Global |
- 97 Pages |
- GIR (Global Info Research) |
- Other
Hereditary diseases are those caused by changes in genetic material or controlled by disease-causing genes. Hereditary diseases refer to diseases that are determined wholly or partly by genetic factors, usually congenital or acquired. Be like congenital foolish model, much point to (toe), congenital deafness dumb, hemophilia, these hereditary disease decides to come on completely by genetic factor, and just after be born certain time comes on, want to pass a few years sometimes, more than ten years even ability after decades appears apparent symptom.At present, China has adopted a variety of neonatal disease screening technologies for early diagnosis and treatment of children with genetic diseases without clinical symptoms, effectively reducing the disability rate and mortality rate of children, and greatly reducing the serious harm caused by birth defects to families and society. In recent years, with the rapid development of molecular biology and genomics, genetic testing technology has become the gold standard when it comes to most of the hereditary disease diagnosis, especially in the biochemical or enzymatic method can"t make a diagnosis and test results under the condition of not clear, genetic testing is an important means of diagnosis, but in the field of neonatal hereditary disease screening, genetic testing technology is not yet ripe for applications, Gene screening for neonatal deafness has been reported in China.
According to our (Global Info Research) latest study, the global Genetic Disease Diagnostic market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.
In China markets, the core manufacturers of genetic disease diagnostic includes BGI Group, Berry Genomics etc and the top 5 companies hold a share over 40%.
This report is a detailed and comprehensive analysis for global Genetic Disease Diagnostic market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Genetic Disease Diagnostic market size and forecasts, in consumption value ($ Million), 2019-2030
Global Genetic Disease Diagnostic market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
Global Genetic Disease Diagnostic market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
Global Genetic Disease Diagnostic market shares of main players, in revenue ($ Million), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Genetic Disease Diagnostic
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Genetic Disease Diagnostic market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, PerkinElmer, Roche Diagnostics, Bio Rad, Thermo Fisher Scientific, BGI Group, Berry Genomics, Da An Gene Co., Ltd., Illumina, CapitalBio Technology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Genetic Disease Diagnostic market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segmentation
Genetic Disease Diagnostic market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Prenatal Diagnosis
Screening for Single Gene Genetic Disease
Preimplantation Genetic Testing
Others
Market segment by Application
Hospital
Medical Laboratory
Others
Market segment by players, this report covers
Abbott
PerkinElmer
Roche Diagnostics
Bio Rad
Thermo Fisher Scientific
BGI Group
Berry Genomics
Da An Gene Co., Ltd.
Illumina
CapitalBio Technology
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Genetic Disease Diagnostic product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Genetic Disease Diagnostic, with revenue, gross margin, and global market share of Genetic Disease Diagnostic from 2019 to 2024.
Chapter 3, the Genetic Disease Diagnostic competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Genetic Disease Diagnostic market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Genetic Disease Diagnostic.
Chapter 13, to describe Genetic Disease Diagnostic research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Genetic Disease Diagnostic by Type
- 1.3.1 Overview: Global Genetic Disease Diagnostic Market Size by Type: 2019 Versus 2023 Versus 2030
- 1.3.2 Global Genetic Disease Diagnostic Consumption Value Market Share by Type in 2023
- 1.3.3 Prenatal Diagnosis
- 1.3.4 Screening for Single Gene Genetic Disease
- 1.3.5 Preimplantation Genetic Testing
- 1.3.6 Others
- 1.4 Global Genetic Disease Diagnostic Market by Application
- 1.4.1 Overview: Global Genetic Disease Diagnostic Market Size by Application: 2019 Versus 2023 Versus 2030
- 1.4.2 Hospital
- 1.4.3 Medical Laboratory
- 1.4.4 Others
- 1.5 Global Genetic Disease Diagnostic Market Size & Forecast
- 1.6 Global Genetic Disease Diagnostic Market Size and Forecast by Region
- 1.6.1 Global Genetic Disease Diagnostic Market Size by Region: 2019 VS 2023 VS 2030
- 1.6.2 Global Genetic Disease Diagnostic Market Size by Region, (2019-2030)
- 1.6.3 North America Genetic Disease Diagnostic Market Size and Prospect (2019-2030)
- 1.6.4 Europe Genetic Disease Diagnostic Market Size and Prospect (2019-2030)
- 1.6.5 Asia-Pacific Genetic Disease Diagnostic Market Size and Prospect (2019-2030)
- 1.6.6 South America Genetic Disease Diagnostic Market Size and Prospect (2019-2030)
- 1.6.7 Middle East & Africa Genetic Disease Diagnostic Market Size and Prospect (2019-2030)
2 Company Profiles
- 2.1 Abbott
- 2.1.1 Abbott Details
- 2.1.2 Abbott Major Business
- 2.1.3 Abbott Genetic Disease Diagnostic Product and Solutions
- 2.1.4 Abbott Genetic Disease Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
- 2.1.5 Abbott Recent Developments and Future Plans
- 2.2 PerkinElmer
- 2.2.1 PerkinElmer Details
- 2.2.2 PerkinElmer Major Business
- 2.2.3 PerkinElmer Genetic Disease Diagnostic Product and Solutions
- 2.2.4 PerkinElmer Genetic Disease Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
- 2.2.5 PerkinElmer Recent Developments and Future Plans
- 2.3 Roche Diagnostics
- 2.3.1 Roche Diagnostics Details
- 2.3.2 Roche Diagnostics Major Business
- 2.3.3 Roche Diagnostics Genetic Disease Diagnostic Product and Solutions
- 2.3.4 Roche Diagnostics Genetic Disease Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
- 2.3.5 Roche Diagnostics Recent Developments and Future Plans
- 2.4 Bio Rad
- 2.4.1 Bio Rad Details
- 2.4.2 Bio Rad Major Business
- 2.4.3 Bio Rad Genetic Disease Diagnostic Product and Solutions
- 2.4.4 Bio Rad Genetic Disease Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
- 2.4.5 Bio Rad Recent Developments and Future Plans
- 2.5 Thermo Fisher Scientific
- 2.5.1 Thermo Fisher Scientific Details
- 2.5.2 Thermo Fisher Scientific Major Business
- 2.5.3 Thermo Fisher Scientific Genetic Disease Diagnostic Product and Solutions
- 2.5.4 Thermo Fisher Scientific Genetic Disease Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
- 2.5.5 Thermo Fisher Scientific Recent Developments and Future Plans
- 2.6 BGI Group
- 2.6.1 BGI Group Details
- 2.6.2 BGI Group Major Business
- 2.6.3 BGI Group Genetic Disease Diagnostic Product and Solutions
- 2.6.4 BGI Group Genetic Disease Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
- 2.6.5 BGI Group Recent Developments and Future Plans
- 2.7 Berry Genomics
- 2.7.1 Berry Genomics Details
- 2.7.2 Berry Genomics Major Business
- 2.7.3 Berry Genomics Genetic Disease Diagnostic Product and Solutions
- 2.7.4 Berry Genomics Genetic Disease Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
- 2.7.5 Berry Genomics Recent Developments and Future Plans
- 2.8 Da An Gene Co., Ltd.
- 2.8.1 Da An Gene Co., Ltd. Details
- 2.8.2 Da An Gene Co., Ltd. Major Business
- 2.8.3 Da An Gene Co., Ltd. Genetic Disease Diagnostic Product and Solutions
- 2.8.4 Da An Gene Co., Ltd. Genetic Disease Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
- 2.8.5 Da An Gene Co., Ltd. Recent Developments and Future Plans
- 2.9 Illumina
- 2.9.1 Illumina Details
- 2.9.2 Illumina Major Business
- 2.9.3 Illumina Genetic Disease Diagnostic Product and Solutions
- 2.9.4 Illumina Genetic Disease Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
- 2.9.5 Illumina Recent Developments and Future Plans
- 2.10 CapitalBio Technology
- 2.10.1 CapitalBio Technology Details
- 2.10.2 CapitalBio Technology Major Business
- 2.10.3 CapitalBio Technology Genetic Disease Diagnostic Product and Solutions
- 2.10.4 CapitalBio Technology Genetic Disease Diagnostic Revenue, Gross Margin and Market Share (2019-2024)
- 2.10.5 CapitalBio Technology Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Genetic Disease Diagnostic Revenue and Share by Players (2019-2024)
- 3.2 Market Share Analysis (2023)
- 3.2.1 Market Share of Genetic Disease Diagnostic by Company Revenue
- 3.2.2 Top 3 Genetic Disease Diagnostic Players Market Share in 2023
- 3.2.3 Top 6 Genetic Disease Diagnostic Players Market Share in 2023
- 3.3 Genetic Disease Diagnostic Market: Overall Company Footprint Analysis
- 3.3.1 Genetic Disease Diagnostic Market: Region Footprint
- 3.3.2 Genetic Disease Diagnostic Market: Company Product Type Footprint
- 3.3.3 Genetic Disease Diagnostic Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Genetic Disease Diagnostic Consumption Value and Market Share by Type (2019-2024)
- 4.2 Global Genetic Disease Diagnostic Market Forecast by Type (2025-2030)
5 Market Size Segment by Application
- 5.1 Global Genetic Disease Diagnostic Consumption Value Market Share by Application (2019-2024)
- 5.2 Global Genetic Disease Diagnostic Market Forecast by Application (2025-2030)
6 North America
- 6.1 North America Genetic Disease Diagnostic Consumption Value by Type (2019-2030)
- 6.2 North America Genetic Disease Diagnostic Market Size by Application (2019-2030)
- 6.3 North America Genetic Disease Diagnostic Market Size by Country
- 6.3.1 North America Genetic Disease Diagnostic Consumption Value by Country (2019-2030)
- 6.3.2 United States Genetic Disease Diagnostic Market Size and Forecast (2019-2030)
- 6.3.3 Canada Genetic Disease Diagnostic Market Size and Forecast (2019-2030)
- 6.3.4 Mexico Genetic Disease Diagnostic Market Size and Forecast (2019-2030)
7 Europe
- 7.1 Europe Genetic Disease Diagnostic Consumption Value by Type (2019-2030)
- 7.2 Europe Genetic Disease Diagnostic Consumption Value by Application (2019-2030)
- 7.3 Europe Genetic Disease Diagnostic Market Size by Country
- 7.3.1 Europe Genetic Disease Diagnostic Consumption Value by Country (2019-2030)
- 7.3.2 Germany Genetic Disease Diagnostic Market Size and Forecast (2019-2030)
- 7.3.3 France Genetic Disease Diagnostic Market Size and Forecast (2019-2030)
- 7.3.4 United Kingdom Genetic Disease Diagnostic Market Size and Forecast (2019-2030)
- 7.3.5 Russia Genetic Disease Diagnostic Market Size and Forecast (2019-2030)
- 7.3.6 Italy Genetic Disease Diagnostic Market Size and Forecast (2019-2030)
8 Asia-Pacific
- 8.1 Asia-Pacific Genetic Disease Diagnostic Consumption Value by Type (2019-2030)
- 8.2 Asia-Pacific Genetic Disease Diagnostic Consumption Value by Application (2019-2030)
- 8.3 Asia-Pacific Genetic Disease Diagnostic Market Size by Region
- 8.3.1 Asia-Pacific Genetic Disease Diagnostic Consumption Value by Region (2019-2030)
- 8.3.2 China Genetic Disease Diagnostic Market Size and Forecast (2019-2030)
- 8.3.3 Japan Genetic Disease Diagnostic Market Size and Forecast (2019-2030)
- 8.3.4 South Korea Genetic Disease Diagnostic Market Size and Forecast (2019-2030)
- 8.3.5 India Genetic Disease Diagnostic Market Size and Forecast (2019-2030)
- 8.3.6 Southeast Asia Genetic Disease Diagnostic Market Size and Forecast (2019-2030)
- 8.3.7 Australia Genetic Disease Diagnostic Market Size and Forecast (2019-2030)
9 South America
- 9.1 South America Genetic Disease Diagnostic Consumption Value by Type (2019-2030)
- 9.2 South America Genetic Disease Diagnostic Consumption Value by Application (2019-2030)
- 9.3 South America Genetic Disease Diagnostic Market Size by Country
- 9.3.1 South America Genetic Disease Diagnostic Consumption Value by Country (2019-2030)
- 9.3.2 Brazil Genetic Disease Diagnostic Market Size and Forecast (2019-2030)
- 9.3.3 Argentina Genetic Disease Diagnostic Market Size and Forecast (2019-2030)
10 Middle East & Africa
- 10.1 Middle East & Africa Genetic Disease Diagnostic Consumption Value by Type (2019-2030)
- 10.2 Middle East & Africa Genetic Disease Diagnostic Consumption Value by Application (2019-2030)
- 10.3 Middle East & Africa Genetic Disease Diagnostic Market Size by Country
- 10.3.1 Middle East & Africa Genetic Disease Diagnostic Consumption Value by Country (2019-2030)
- 10.3.2 Turkey Genetic Disease Diagnostic Market Size and Forecast (2019-2030)
- 10.3.3 Saudi Arabia Genetic Disease Diagnostic Market Size and Forecast (2019-2030)
- 10.3.4 UAE Genetic Disease Diagnostic Market Size and Forecast (2019-2030)
11 Market Dynamics
- 11.1 Genetic Disease Diagnostic Market Drivers
- 11.2 Genetic Disease Diagnostic Market Restraints
- 11.3 Genetic Disease Diagnostic Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
12 Industry Chain Analysis
- 12.1 Genetic Disease Diagnostic Industry Chain
- 12.2 Genetic Disease Diagnostic Upstream Analysis
- 12.3 Genetic Disease Diagnostic Midstream Analysis
- 12.4 Genetic Disease Diagnostic Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Genetic Disease Diagnostic. Industry analysis & Market Report on Genetic Disease Diagnostic is a syndicated market report, published as Global Genetic Disease Diagnostic Market 2024 by Company, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Genetic Disease Diagnostic market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
